Entecavir -Anqing World Chemical Co.,LTD. Entecavir monohydrate API Entecavir
Anqing World chemical co., LTD., which is a subsidiary of Anhui hai kang pharmaceutical co., LTD. ,was founded in 2010. It is specialized in the manufacture and sales of pharmaceutical intermediates. And it also reached the production value of 20 million RMB in 2012.
The company is mainly responsible for anhui hai kang pharmaceutical Co., LTD.,about Technology research and development and product screening, and related products sales.
Entecavir INN /?n?t?k?v??r/ en-TEK-a-vir, abbreviated ETV, is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade names Baraclude (BMS) and Entaliv (DRL).
Entecavir is a nucleoside analog[2] (more specifically, a guanosine analogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. The drug's manufacturer claims that entecavir is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir).
Entecavir was approved by the U.S. FDA in March 2005.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View